Author

T. Gonda

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. H. H. Sara· 1 shared A. Heguy· 1 shared A. Hunyadi· 1 shared A. Tsirigos· 1 shared A. W. Lund· 1 shared B. A. Tayeb· 1 shared C. A. Loomis· 1 shared C. Hajdu· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. H. H. Sara

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Thymoquinone-Protoflavone Hybrid Molecules as Potential Antitumor Agents

A. H. H. Sara, B. A. Tayeb, T. Gonda, G. Girst, K. Szori, R. Berkecz, I. Zupko, R. Minorics, A. Hunyadi

The paper synthesizes eight thymoquinone-protoflavone hybrids and tests their antitumor activity, finding compound 14 shows strong activity against breast and glioblastoma cells.

bioRxiv · Sep 4, 2023Pharmacology & Toxicology

Single-Cell RNA Sequencing Reveals the Effects of Chemotherapy on Human Pancreatic Adenocarcinoma and its Tumor Microenvironment

G. Werba, D. Weissinger, E. A. Kawaler, E. Zhao, D. Kalfakakou, S. Dhara, G. Oh, X. Jing, N. Beri, L. Khanna, T. Gonda, P. Oberstein, C. Hajdu, C. A. Loomis, A. Heguy, , D. M. Simeone

This study uses single-cell RNA sequencing to analyze how chemotherapy affects PDAC tumor cells and their microenvironment, finding limited transcriptional shifts and reduced TIGIT-mediated immune checkpoint activity.

bioRxiv · May 24, 2022Cancer Biology